Biosimilar Drugs | search
Click here to view Biosimilar Drugs news from 60+ newspapers.
Bookmark or Share- Biosimilar Product Information | FDA - U.S. Food and Drug AdministrationThis page includes a chart of the approved biosimilar and interchangeable products. The approval of biosimilar products can improve access to care for patients by increasing the number of...
- Biosimilar medicines: Overview - European Medicines Agency (EMA)A biosimilar is a biological medicine highly similar to another already approved biological medicine (the 'reference medicine'). Biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines.
- Biologics vs. Biosimilars: Understanding the DifferenceBiosimilars are a class of drugs designed to increase access for patients who need treatment with a biologic medicine.
- 20 Common Biosimilar Drugs in the U.S. - GoodRxMany biosimilar drugs are available in the U.S. Between 2015 and 2022, 40 biosimilars were approved for use. Top examples include Inflectra, Mvasi, and Zarxio. A few interchangeable biosimilars, like Semglee and Cimerli, are also available.
- Biosimilars Basics for Patients | FDA - U.S. Food and Drug AdministrationBiosimilars are safe and effective medications for treating many illnesses such as arthritis and cancer. Learn about biosimilars and how they benefit patients.
More
